In vitro glucuronidation of aprepitant: a moderate inhibitor of UGT2B7.

House, Larry; Ramirez, Jacqueline; Seminerio, Michael; Mirkov, Snezana; Ratain, Mark J

House, Larry; Ramirez, Jacqueline; Seminerio, Michael; Mirkov, Snezana; Ratain, Mark J.

Afiliación

House L; a Department of Medicine , University of Chicago , Chicago , IL , USA.
Ramirez J; a Department of Medicine , University of Chicago , Chicago , IL , USA.
Seminerio M; a Department of Medicine , University of Chicago , Chicago , IL , USA.
Mirkov S; a Department of Medicine , University of Chicago , Chicago , IL , USA.
Ratain MJ; a Department of Medicine , University of Chicago , Chicago , IL , USA.

Xenobiotica ; 45(11): 990-8, 2015.

Article en En | MEDLINE | ID: mdl-26053558

Asunto(s)

Inhibidores Enzimáticos/química; Glucuronosiltransferasa/antagonistas & inhibidores; Glucuronosiltransferasa/química; Morfolinas/química; Aprepitant; Citocromo P-450 CYP3A/química; Humanos

Palabras clave

Aprepitant; drug metabolism; phase II

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Morfolinas / Glucuronosiltransferasa / Inhibidores Enzimáticos Límite: Humans Idioma: En Revista: Xenobiotica Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google